非急性白血病髓系肿瘤诊断与生物学中的基因检测
本文总结2017年血液病理学会/欧洲血液病理学协会研讨会关于基因检测在非急性白血病髓系肿瘤诊断中的作用。研讨会将98例提交病例归入该类别,其中13例选作口头报告。结论强调基因异常对诊断、分类和预后有重要影响,但需结合形态学和临床特征审慎解读。
要点
- 常规核型和基因测序结果对非急性白血病髓系肿瘤的诊断、分类和预后有重要影响。
- 部分病例的基因结果与形态学和/或临床特征不一致,需病理医生和临床医生结合其他发现审慎管理基因数据。
- 许多基因异常已纳入最新WHO分类,未来分类中将日益重要。
核心结论
- 基因异常在非急性白血病髓系肿瘤的诊断和治疗中具有重要意义。
- 许多基因数据已纳入最新WHO分类,未来分类中将日益重要。
研究设计与样本
- 2017年血液病理学会/欧洲血液病理学协会研讨会将98例提交病例归入非急性白血病髓系肿瘤类别,其中13例选作口头报告。
主要发现
- 常规核型和基因测序数据对诊断、分类和预后有重要影响。
- 部分病例的基因结果与形态学和/或临床特征不一致。
临床怎么用
- 病理医生和临床医生需结合其他发现审慎管理基因数据,以应对基因结果与形态学/临床特征不一致的情况。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The 2017 Workshop of the Society for Hematopathology/European Association for Haematopathology reviewed the role of genetic testing in the diagnosis of hematopoietic neoplasms, including non-acute leukemia myeloid malignancies. METHODS: The workshop panel assigned 98 submitted cases to the category of non-acute leukemia myeloid neoplasms, of which 13 were selected for oral presentation. RESULTS: Data from both conventional karyotyping and genetic sequencing had important impact on diagnosis, classification, and prognostication. However, some cases had genetic results that appeared discordant from the morphology and/or clinical features. Thus, the workshop underscored the need for careful management of genetic data by the pathologist and clinician, in the context of other findings. CONCLUSIONS: The workshop cases highlighted the significance of genetic aberrations in the diagnosis and treatment of non-acute leukemia myeloid neoplasms. Many genetic data have already been incorporated in the most recent World Health Organization classification, and undoubtedly they will factor increasingly in future classifications.
引用
- Hasserjian RP, Kelley TW, Weinberg OK, et al. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias). Am J Clin Pathol. 2019. PMID: 31263893. doi:10.1093/ajcp/aqz069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。